ZAP70 and B-cell chronic lymphocytic leukemia: Further elucidation of the role and modulation of signals from the microenvironment and especially from CXCR4 can contribute to enlighten the biology behind the adverse clinical outcome of patients with CLL and high expression of ZAP-70, and can potentially be exploited for the development of new treatments.